ONCOTHYREON INC.

Profile

Company Names

ONCOTHYREON INC.

Addresses

2601 FOURTH AVENUE, SUITE 500, SEATTLE, WA 98121

Phone Numbers

(206) 801-2100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$38,061,473.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2014-08-08 
$22,861,428.00 
$22,861,428.00 
$0.00 
Equity 
3
2011-02-08 
$150,000.00 
INDEFINITE 
INDEFINITE 
 
2
2010-09-28 
$14,850,045.00 
$28,342,348.00 
$13,492,303.00 
Equity 
1
2010-07-06 
$200,000.00 
$20,200,000.00 
$20,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
 
CHRISTIANSON 
EXECUTIVE OFFICER
ONCOTHYREON INC.   |  NOHLA THERAPEUTICS INC.
JULIA 
 
EASTLAND 
EXECUTIVE OFFICER
ONCOTHYREON INC.   |  RECODE THERAPEUTICS, INC.
JULIA 
MARIE 
EASTLAND 
EXECUTIVE OFFICER
ONCOTHYREON INC.
DIANA 
 
HAUSMAN 
EXECUTIVE OFFICER
ONCOTHYREON INC.
CHRISTOPHER 
 
HENNEY 
DIRECTOR
CYCLACEL PHARMACEUTICALS, INC.   |  ONCOTHYREON INC.
CHRISTOPHER 
S. 
HENNEY 
DIRECTOR
ONCOTHYREON INC.   |  CYCLACEL PHARMACEUTICALS, INC.
RICHARD 
 
JACKSON 
DIRECTOR
ONCOTHYREON INC.   |  TAILWIND PREMIER HOLDINGS, LLC
RICHARD 
L. 
JACKSON 
DIRECTOR
ONCOTHYREON INC.
SHASHI 
K. 
KARAN 
EXECUTIVE OFFICER
ONCOTHYREON INC.
ROBERT 
L. 
KIRKMAN 
EXECUTIVE OFFICER, DIRECTOR
ONCOTHYREON INC.
TED 
W. 
LOVE 
DIRECTOR
AFFYMAX INC   |  ARCA BIOPHARMA, INC.   |  AMICUS THERAPEUTICS INC   |  ONCOTHYREON INC.   |  GLOBAL BLOOD THERAPEUTICS, INC.
SCOTT 
 
PETERSON 
EXECUTIVE OFFICER
ONCOTHYREON INC.   |  OMADI, INC.   |  COLOVORE LLC   |  EXCELERARX CORP.   |  EVERGREEN POINTE TOWNHOMES, LLC   |  THUNDER BIOTECH, INC.
DANIEL 
 
SPIEGELMAN 
DIRECTOR
AFFYMAX INC   |  ONCOTHYREON INC.   |  SPRUCE BIOSCIENCES, INC.
DANIEL 
K. 
SPIEGELMAN 
DIRECTOR
ONCOTHYREON INC.   |  CYCLACEL PHARMACEUTICALS, INC.
W. 
VICKERY 
STOUGHTON 
DIRECTOR
ONCOTHYREON INC.
JAY 
 
VENKATESAN 
EXECUTIVE OFFICER
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
DOUGLAS 
 
WILLIAMS 
DIRECTOR
SINGULAR LOGIC, LLC   |  ONCOTHYREON INC.   |  FOR THE USER, INC.   |  CYTOIMMUNE THERAPEUTICS, INC.   |  GULF COAST FUEL SUPPLY, LLC   |  CARE CONTINUITY, INC.   |  CLIMB BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-08-15
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-08-08 
2011-02-17
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
 
2011-02-08 
2010-10-06
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2010-09-28 
2010-07-15
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2010-07-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JMP SECURITIES LLC
22208
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
FINANCIAL WEST GROUP
16668
REEDLAND CAPITAL PARTNERS
NONE